MIDTERM MEETING OF THE EXANDAS RESEARCH PROGRAM PARTICIPANTS IN THE CONTEXT OF Η2020-MSCA-RISE 2015

12/06/2017|All articles, Horizon 2020, Research & development|

The first meeting of the research program under the distinct title “EXANDAS” of the Marie Sklodowska Curie Actions (MSCA) program successfully took place on 21-22 April 2017. The program aims to exploit the aromatic plants’ by-products, Chios Mastic included, for the purpose of developing novel pharmaceutical products. The program’s coordinator is Assistant Prof. N. Aligiannis, [...]

KICK OFF MEETING OF THE ΕΧΑΝDAS PROGRAM

14/04/2016|All articles, Horizon 2020, Research & development|

ATHENS, 01-02/04/2016 The kick-off meeting of the research program under the distinct title   “EXANDAS” of the Marie Sklodowska Curie Actions (MSCA) programs was successfully organized on 1-2 April 2016. The specific program aims  to exploit the aromatic plants’ by-products such as the Chios Mastic for the purpose of developing novel pharmaceutical products. The meeting took place [...]

PARICIPATION IN THE HORIZON PROGRAM

18/11/2015|All articles, Horizon 2020, Research & development|

BRUSSELS, 10/11/2015 IASIS PHARMA proudly announces its participation in a program of H2020. The program Horizon 2020 is the financing framework of the EU for research and Innovation that will cover the period 2014-2020, with a budget of approximately 80 billion Euros. The program supports the strategy "Europe 2020" that promotes research and innovation as the [...]

Load More Posts